This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laureti, S. Articles by Falorni, A. Search for Related Content PubMed PubMed Citation Articles by Laureti, S. Articles by Falorni, A.

Levels of Adrenocortical Autoantibodies Correlate with the Degree of Adrenal Dysfunction in Subjects with Preclinical Addison’s Disease¹

Department of Internal Medicine and Endocrine and Metabolic Sciences (S.L., F.C., F.S., A.F.), University of Perugia, 06126 Perugia, Italy; Institute of Endocrinology (A.D.B., V.I.M., A.Be.) and Department of Clinical and Experimental Medicine "F. Magrassi" (A.Bi.), 2nd University of Naples, 80131 Naples, Italy; and Department of Molecular and Clinical Endocrinology and Oncology (R.R.), University "Federico II", 80131 Naples, Italy.

Address all correspondence and requests for reprints to: Alberto Falorni, M.D., Ph.D., Department of Internal Medicine and Endocrine and Metabolic Sciences, University of Perugia, Via E. Dal Pozzo, 06126 Perugia, Italy. E-mail: falorni{at}dimisem.med.unipg.it

To test the hypothesis that levels of adrenal autoantibodies correlate with the degree of adrenal dysfunction, we followed up adrenal cortex autoantibody (ACA) titers and 21-hydroxylase (21OH) autoantibody (21OHAb) levels in 19 ACA-positive subjects with preclinical Addison’s disease. On enrollment, all the 19 ACA-positive subjects were positive for 21OHAb. At follow-up, the concordance rate for simultaneous presence/absence of both ACA and 21OHAb was as high as 91% and a strong, positive correlation between 21OHAb levels and ACA titers was observed (P < 0.0001). The levels of adrenal autoantibodies were positively associated with the severity of adrenal dysfunction (ANOVA, P < 0.0001 for both 21OHAb and ACA): the 21OH index was significantly lower at stage 0 or 1 than at stage 2+3 (corrected P < 0.001 and P < 0.05) or stage 4 (corrected P < 0.001 and <0.01). Similarly, ACA titer at stage 4 was significantly higher than stage 0 (P < 0.001), stage 1 (P < 0.001), and stage 2+3 (P < 0.05); and ACA titer at stage 2+3 was higher than stage 0 (P < 0.001) and stage 1 (P < 0.05). In subjects with progression of adrenal dysfunction (n = 14), levels of 21OHAb and ACA increased significantly (P = 0.041 and P = 0.002) during the follow-up period. In 5 subjects, the remission of biochemical signs of adrenal dysfunction was associated with the disappearance of both ACA and 21OHAb. Our study shows that the levels of adrenal autoantibodies correlate with the degree of adrenal dysfunction, and this suggests that production of high-level 21OHAb strongly signals the destructive phase of the autoimmune disease process.

This article has been cited by other articles:

				M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF]

				R. Giordano, M. Balbo, A. Picu, L. Bonelli, R. Berardelli, A. Falorni, E. Ghigo, and E. Arvat Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? Eur. J. Endocrinol., September 1, 2006; 155(3): 421 - 428. [Abstract] [Full Text] [PDF]

				G. Coco, C. Dal Pra, F. Presotto, M. P. Albergoni, C. Canova, B. Pedini, R. Zanchetta, S. Chen, J. Furmaniak, B. Rees Smith, et al. Estimated Risk for Developing Autoimmune Addison's Disease in Patients with Adrenal Cortex Autoantibodies J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1637 - 1645. [Abstract] [Full Text] [PDF]

				R. Salvatori Incidental Adrenal Insufficiency--Reply JAMA, March 8, 2006; 295(10): 1124 - 1124. [Full Text] [PDF]

				M. Rotondi, A. Falorni, A. De Bellis, S. Laureti, P. Ferruzzi, P. Romagnani, A. Buonamano, E. Lazzeri, C. Crescioli, M. Mannelli, et al. Elevated Serum Interferon-{gamma}-Inducible Chemokine-10/CXC Chemokine Ligand-10 in Autoimmune Primary Adrenal Insufficiency and in Vitro Expression in Human Adrenal Cells Primary Cultures after Stimulation with Proinflammatory Cytokines J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2357 - 2363. [Abstract] [Full Text] [PDF]

				J. M. Barker, A. Ide, C. Hostetler, L. Yu, D. Miao, P. R. Fain, G. S. Eisenbarth, and P. A. Gottlieb Endocrine and Immunogenetic Testing in Individuals with Type 1 Diabetes and 21-Hydroxylase Autoantibodies: Addison's Disease in a High-Risk Population J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 128 - 134. [Abstract] [Full Text] [PDF]

				A. Falorni, S. Laureti, A. De Bellis, R. Zanchetta, C. Tiberti, G. Arnaldi, V. Bini, P. Beck-Peccoz, A. Bizzarro, F. Dotta, et al. Italian Addison Network Study: Update of Diagnostic Criteria for the Etiological Classification of Primary Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1598 - 1604. [Abstract] [Full Text] [PDF]

				R. Giordano, M. Pellegrino, S. Oleandri, M. Baldi, M. Balbo, S. Laureti, A. Falorni, E. Ghigo, and E. Arvat Adrenal Sensitivity to Adrenocorticotropin 1-24 Is Reduced in Patients with Autoimmune Polyglandular Syndrome J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 675 - 680. [Abstract] [Full Text] [PDF]

				A. De Bellis, A. Bizzarro, M. Conte, S. Perrino, C. Coronella, S. Solimeno, A. M. Sinisi, L. A. Stile, G. Pisano, and A. Bellastella Antipituitary Antibodies in Adults with Apparently Idiopathic Growth Hormone Deficiency and in Adults with Autoimmune Endocrine Diseases J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 650 - 654. [Abstract] [Full Text] [PDF]

				A. De Bellis, A. Colao, A. Bizzarro, F. Di Salle, C. Coronella, S. Solimeno, A. Vetrano, R. Pivonello, G. Pisano, G. Lombardi, et al. Longitudinal Study of Vasopressin-Cell Antibodies and of Hypothalamic-Pituitary Region on Magnetic Resonance Imaging in Patients with Autoimmune and Idiopathic Complete Central Diabetes Insipidus J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3825 - 3829. [Abstract] [Full Text] [PDF]

				V.K. Bakalov, V.H. Vanderhoof, C.A. Bondy, and L.M. Nelson Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure Hum. Reprod., August 1, 2002; 17(8): 2096 - 2100. [Abstract] [Full Text] [PDF]

				C. Betterle, C. Dal Pra, F. Mantero, and R. Zanchetta Autoimmune Adrenal Insufficiency and Autoimmune Polyendocrine Syndromes: Autoantibodies, Autoantigens, and Their Applicability in Diagnosis and Disease Prediction Endocr. Rev., June 1, 2002; 23(3): 327 - 364. [Abstract] [Full Text] [PDF]

				A. De Bellis, A. Falorni, S. Laureti, S. Perrino, C. Coronella, F. Forini, E. Bizzarro, A. Bizzarro, G. Abbate, and A. Bellastella Time Course of 21-Hydroxylase Antibodies and Long-Term Remission of Subclinical Autoimmune Adrenalitis after Corticosteroid Therapy: Case Report J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 675 - 678. [Abstract] [Full Text]

				G. Gambelunghe, A. Falorni, M. Ghaderi, S. Laureti, C. Tortoioli, F. Santeusanio, P. Brunetti, and C. B. Sanjeevi Microsatellite Polymorphism of the MHC Class I Chain-Related (MIC-A and MIC-B) Genes Marks the Risk for Autoimmune Addison's Disease J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3701 - 3707. [Abstract] [Full Text] [PDF]

				S. Laureti, L. Vecchi, F. Santeusanio, and A. Falorni Is the Prevalence of Addison's Disease Underestimated? J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1762 - 1762. [Full Text]